| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Lewis Kuller | Q88077314 |
| Masafumi Ihara | Q42656310 | ||
| Akira Sekikawa | Q42738149 | ||
| P2093 | author name string | Oscar Lopez | |
| Howard Aizenstein | |||
| Yue-Fang Chang | |||
| Yoshihiro Miyamoto | |||
| Aya Higashiyama | |||
| Brian Lopresti | |||
| Chester Mathis | |||
| Chikage Kakuta | |||
| Chendi Cui | |||
| P2860 | cites work | Plasma isoflavone concentration is associated with decreased risk of type 2 diabetes in Korean women but not men: results from the Korean Genome and Epidemiology Study. | Q53243862 |
| Mechanisms, Pathophysiology, and Therapy of Arterial Stiffness | Q22306395 | ||
| The identification of the weak oestrogen equol [7-hydroxy-3-(4'-hydroxyphenyl)chroman] in human urine | Q24531190 | ||
| Equol, a new inactive phenol isolated from the ketohydroxyoestrin fraction of mares' urine | Q24537120 | ||
| Equol: pharmacokinetics and biological actions | Q24594626 | ||
| Equol: history, chemistry, and formation | Q24594674 | ||
| A preliminary study of the safety, feasibility and cognitive efficacy of soy isoflavone supplements in older men and women | Q24657278 | ||
| The impact of equol-producing status in modifying the effect of soya isoflavones on risk factors for CHD: a systematic review of randomised controlled trials | Q26740096 | ||
| East meets West: ethnic differences in prostate cancer epidemiology between East Asians and Caucasians | Q26827438 | ||
| Mannheim carotid intima-media thickness and plaque consensus (2004-2006-2011) | Q26863741 | ||
| Comparison of coronary artery calcium presence, carotid plaque presence, and carotid intima-media thickness for cardiovascular disease prediction in the Multi-Ethnic Study of Atherosclerosis | Q27340038 | ||
| Soy and Health Update: Evaluation of the Clinical and Epidemiologic Literature | Q28071946 | ||
| The role of colonic bacteria in the metabolism of the natural isoflavone daidzin to equol | Q28087603 | ||
| Comparison of isoflavones among dietary intake, plasma concentration and urinary excretion for accurate estimation of phytoestrogen intake | Q28142763 | ||
| Interindividual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut microflora | Q28143631 | ||
| Soya isoflavone consumption in relation to carotid intima-media thickness in Chinese equol excretors aged 40-65 years. | Q51360435 | ||
| Soy food consumption does not lower LDL cholesterol in either equol or nonequol producers. | Q51443144 | ||
| Consumption of isoflavone-rich soy protein does not alter homocysteine or markers of inflammation in postmenopausal women. | Q51463971 | ||
| Effects of high- and low-isoflavone soyfoods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women. | Q51541715 | ||
| Effect of soy-based breakfast cereal on blood lipids and oxidized low-density lipoprotein. | Q51552502 | ||
| Dietary seaweed modifies estrogen and phytoestrogen metabolism in healthy postmenopausal women. | Q51751035 | ||
| Soy consumption and mortality in Hong Kong: proxy-reported case-control study of all older adult deaths in 1998. | Q51809177 | ||
| Dementia and Alzheimer's disease incidence in relationship to cardiovascular disease in the Cardiovascular Health Study cohort. | Q51926808 | ||
| Pulse pressure and pulse wave velocity are related to cognitive decline in the Baltimore Longitudinal Study of Aging. | Q51969591 | ||
| Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis | Q37719080 | ||
| Effects of soy isoflavone extract supplements on blood pressure in adult humans: systematic review and meta-analysis of randomized placebo-controlled trials | Q37767581 | ||
| Are changes in carotid intima-media thickness related to risk of nonfatal myocardial infarction? A critical review and meta-regression analysis | Q37799120 | ||
| Microvascular brain damage with aging and hypertension: pathophysiological consideration and clinical implications. | Q37876175 | ||
| Added value of CAC in risk stratification for cardiovascular events: a systematic review. | Q37885385 | ||
| Emerging evidence of the health benefits of S-equol, an estrogen receptor β agonist | Q37905857 | ||
| Prostate cancer chemoprevention study: an investigative randomized control study using purified isoflavones in men with rising prostate-specific antigen | Q37944367 | ||
| Lessons from the past and promises for the future for carotid intima-media thickness | Q38045604 | ||
| The timing hypothesis and hormone replacement therapy: a paradigm shift in the primary prevention of coronary heart disease in women. Part 2: comparative risks | Q38108388 | ||
| East is east and West is west: perspectives on the menopause in Asia and The West. | Q38127851 | ||
| Geographic and ethnic disparities in osteoporotic fractures | Q38206067 | ||
| Do soy isoflavones improve cognitive function in postmenopausal women? A meta-analysis | Q38227255 | ||
| Carotid intima-media thickness and plaque in cardiovascular risk assessment | Q38232754 | ||
| A major role for cardiovascular burden in age-related cognitive decline | Q38316448 | ||
| Carotid intima-media thickness is associated with the progression of cognitive impairment in older adults | Q38428121 | ||
| Estrogen receptor alpha and beta in health and disease | Q38572801 | ||
| Arterial stiffness, atherosclerosis and cardiovascular risk: Pathophysiologic mechanisms and emerging clinical indications | Q38661611 | ||
| Coronary Artery Calcium and Risk of Dementia in MESA (Multi-Ethnic Study of Atherosclerosis). | Q38808012 | ||
| Cross-sectional study of equol producer status and cognitive impairment in older adults | Q38874737 | ||
| Differences in incidence, mortality and survival of breast cancer by regions and countries in Asia and contributing factors | Q39020291 | ||
| Relationship between equol producer status and metabolic parameters in 743 Japanese women: equol producer status is associated with antiatherosclerotic conditions in women around menopause and early postmenopause | Q39166861 | ||
| Effect of soybean protein on blood pressure in postmenopausal women: a meta-analysis of randomized controlled trials | Q39413234 | ||
| Association between dietary patterns and cognitive function among 70-year-old Japanese elderly: a cross-sectional analysis of the SONIC study. | Q40047305 | ||
| Age-stratified serum levels of isoflavones and proportion of equol producers in Japanese and Korean healthy men. | Q40136194 | ||
| Serum cholesterol efflux potential in postmenopausal women treated with isolated isoflavones. | Q40293984 | ||
| Significant inverse association of equol-producer status with coronary artery calcification but not dietary isoflavones in healthy Japanese men. | Q40333462 | ||
| Is daidzein non-metabolizer a high risk for prostate cancer? A case-controlled study of serum soybean isoflavone concentration | Q40623843 | ||
| Aortic Stiffness and the Risk of Incident Mild Cognitive Impairment and Dementia | Q40635919 | ||
| Relationship of serum levels and dietary intake of isoflavone, and the novel bacterium Slackia sp. strain NATTS with the risk of prostate cancer: a case-control study among Japanese men. | Q40718691 | ||
| Comparison of Carotid Plaque Score and Coronary Artery Calcium Score for Predicting Cardiovascular Disease Events: The Multi-Ethnic Study of Atherosclerosis | Q41102621 | ||
| Plasma isoflavones and risk of primary liver cancer in Japanese women and men with hepatitis virus infection: a nested case-control study | Q41580096 | ||
| The soybean isoflavonoid equol blocks ritonavir-induced endothelial dysfunction in porcine pulmonary arteries and human pulmonary artery endothelial cells | Q41848164 | ||
| Profiles of phytoestrogens in human urine from several Asian countries | Q42938424 | ||
| Effects of soy isoflavones and genistein on glucose metabolism in perimenopausal and postmenopausal non-Asian women: a meta-analysis of randomized controlled trials | Q43004191 | ||
| Daidzein-metabolising phenotypes in relation to serum lipids and uric acid in adults in Guangzhou, China | Q43141585 | ||
| Plasma isoflavones and the risk of lung cancer in women: a nested case-control study in Japan | Q43429513 | ||
| Dietary soy has both beneficial and potentially adverse cardiovascular effects: a placebo-controlled study in men and postmenopausal women | Q43666501 | ||
| Effects of natural S-equol supplements on overweight or obesity and metabolic syndrome in the Japanese, based on sex and equol status | Q44235042 | ||
| Dietary patterns and risk of dementia in an elderly Japanese population: the Hisayama Study | Q44287374 | ||
| The Association of Coronary Artery Calcium With Noncardiovascular Disease: The Multi-Ethnic Study of Atherosclerosis | Q36880519 | ||
| Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: the Multi-Ethnic Study of Atherosclerosis (MESA). | Q36914416 | ||
| Levels of urinary isoflavones and lignan polyphenols in Japanese women. | Q37170809 | ||
| Dietary factors influence production of the soy isoflavone metabolite s-(-)equol in healthy adults | Q37307326 | ||
| Equol-producing status, isoflavone intake, and breast density in a sample of U.S. Chinese women | Q37324699 | ||
| The LDL modification hypothesis of atherogenesis: an update | Q37326175 | ||
| Carotid intimal medial thickness predicts cognitive decline among adults without clinical vascular disease | Q37366566 | ||
| Pulse pressure is associated with Alzheimer biomarkers in cognitively normal older adults | Q37372458 | ||
| Soy consumption, adhesion molecules, and pro-inflammatory cytokines: a brief review of the literature | Q37427984 | ||
| Consumption of soy foods and isoflavones and risk of type 2 diabetes: a pooled analysis of three US cohorts | Q37482267 | ||
| Prevalence of the equol-producer phenotype and its relationship with dietary isoflavone and serum lipids in healthy Chinese adults | Q37511268 | ||
| Dissociation of aortic pulse wave velocity with risk factors for cardiovascular disease other than hypertension: a systematic review | Q37626339 | ||
| Association of soy food intake with risk and biomarkers of coronary heart disease in Chinese men. | Q37627071 | ||
| Association between arterial stiffness, cerebral small vessel disease and cognitive impairment: A systematic review and meta-analysis | Q37649356 | ||
| Treatment of asymptomatic adults with elevated coronary calcium scores with atorvastatin, vitamin C, and vitamin E: the St. Francis Heart Study randomized clinical trial | Q28182487 | ||
| Method of defining equol-producer status and its frequency among vegetarians | Q28253168 | ||
| Comparisons of percent equol producers between prostate cancer patients and controls: case-controlled studies of isoflavones in Japanese, Korean and American residents | Q28254959 | ||
| Urinary equol excretion with a soy challenge: influence of habitual diet | Q28264036 | ||
| Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee | Q28292284 | ||
| Meta-Analysis of the Effects of Soy Protein Intake on Serum Lipids | Q28292288 | ||
| Prevalence of daidzein-metabolizing phenotypes differs between Caucasian and Korean American women and girls | Q28307160 | ||
| Genistein suppresses the mitochondrial apoptotic pathway in hippocampal neurons in rats with Alzheimer's disease | Q28387305 | ||
| Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association | Q30238784 | ||
| Intima-Media Thickness and Cognitive Function in Stroke-Free Middle-Aged Adults: Findings From the Coronary Artery Risk Development in Young Adults Study. | Q30377984 | ||
| Pulse wave velocity is associated with β-amyloid deposition in the brains of very elderly adults. | Q30409644 | ||
| Carotid atherosclerosis and 10-year changes in cognitive function | Q30448557 | ||
| Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study | Q30475835 | ||
| Recommendations for Improving and Standardizing Vascular Research on Arterial Stiffness: A Scientific Statement From the American Heart Association | Q30666157 | ||
| Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects | Q30696151 | ||
| Effect of soy isoflavones on blood pressure: a meta-analysis of randomized controlled trials | Q30999660 | ||
| Inhibition of postmenopausal atherosclerosis progression: a comparison of the effects of conjugated equine estrogens and soy phytoestrogens | Q32086357 | ||
| Carotid artery atherosclerosis, MRI indices of brain ischemia, aging, and cognitive impairment: the Framingham study | Q33415303 | ||
| Dietary soy intake is not associated with risk of cardiovascular disease mortality in Singapore Chinese adults | Q33602189 | ||
| Isoflavone supplements stimulated the production of serum equol and decreased the serum dihydrotestosterone levels in healthy male volunteers | Q33710326 | ||
| Guidance from an NIH workshop on designing, implementing, and reporting clinical studies of soy interventions | Q33849301 | ||
| Development and Use of a Real-Time Quantitative PCR Method for Detecting and Quantifying Equol-Producing Bacteria in Human Faecal Samples and Slurry Cultures | Q33854671 | ||
| Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo | Q33864159 | ||
| Subclinical Cardiovascular Disease and Death, Dementia, and Coronary Heart Disease in Patients 80+ Years. | Q33886346 | ||
| Effects of isoflavones and amino acid therapies for hot flashes and co-occurring symptoms during the menopausal transition and early postmenopause: a systematic review. | Q33995517 | ||
| Systematic review and meta-analysis of soy products consumption in patients with type 2 diabetes mellitus. | Q34077329 | ||
| Does carotid intima-media thickness regression predict reduction of cardiovascular events? A meta-analysis of 41 randomized trials | Q34153066 | ||
| The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones | Q34162974 | ||
| Systematic review of soy isoflavone supplements on osteoporosis in women | Q34252055 | ||
| Mortality from ischaemic heart disease by country, region, and age: statistics from World Health Organisation and United Nations | Q34315976 | ||
| Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials | Q34337221 | ||
| Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimenopausal women | Q34453087 | ||
| High concordance of daidzein-metabolizing phenotypes in individuals measured 1 to 3 years apart. | Q34475991 | ||
| The isoflavone Equol mediates rapid vascular relaxation: Ca2+-independent activation of endothelial nitric-oxide synthase/Hsp90 involving ERK1/2 and Akt phosphorylation in human endothelial cells. | Q53611576 | ||
| Phytoestrogen concentrations in serum from Japanese men and women over forty years of age. | Q53664315 | ||
| Soya products and serum lipids: a meta-analysis of randomised controlled trials. | Q53679696 | ||
| Isoflavone phytoestrogens consumed in soy decrease F(2)-isoprostane concentrations and increase resistance of low-density lipoprotein to oxidation in humans. | Q54042781 | ||
| Inverse association between soy food consumption, especially fermented soy products intake and soy isoflavone, and arterial stiffness in Japanese men. | Q55434237 | ||
| Aortic Stiffness is Associated with Increased Risk of Incident Dementia in Older Adults | Q57068309 | ||
| Effect of soy isoflavone supplementation on endothelial dysfunction and oxidative stress in equol-producing postmenopausal women | Q57216457 | ||
| Variations in plasma phytoestrogen concentrations in European adults | Q57252094 | ||
| Arterial Stiffness, Cognitive Decline, and Risk of Dementia | Q57781889 | ||
| Atherosclerosis and risk for dementia | Q57781893 | ||
| Soya isoflavone-enriched cereal bars affect markers of endothelial function in postmenopausal women | Q60221139 | ||
| Cardiovascular risk factors and cognitive decline in middle-aged adults | Q60692491 | ||
| Relationship Between Serum Isoflavone Levels and Disability-Free Survival Among Community-Dwelling Elderly Individuals: Nested Case-Control Study of the Tsurugaya Project | Q61197756 | ||
| Effects of Equol Supplement on Bone and Cardiovascular Parameters in Middle-Aged Japanese Women: A Prospective Observational Study. | Q64922559 | ||
| Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study. The CHS Collaborative Research Group | Q67591473 | ||
| Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study | Q71730400 | ||
| The variable metabolic response to dietary isoflavones in humans | Q72635179 | ||
| Food labeling: health claims; soy protein and coronary heart disease. Food and Drug Administration, HHS. Final rule | Q73018621 | ||
| Antioxidant activity of phytoestrogenic isoflavones | Q73034905 | ||
| Wheat bran and soy protein feeding do not alter urinary excretion of the isoflavan equol in premenopausal women | Q73587217 | ||
| Urinary isoflavonoid and lignan excretion on a Western diet: relation to soy, vegetable, and fruit intake | Q73614211 | ||
| Different associations of blood pressure with 24-hour urinary sodium excretion among pre- and post-menopausal women. WHO Cardiovascular Diseases and Alimentary Comparison (WHO-CARDIAC) Study | Q73816558 | ||
| Soy protein versus soy phytoestrogens in the prevention of diet-induced coronary artery atherosclerosis of male cynomolgus monkeys | Q73965734 | ||
| Antioxidant activities of isoflavones and their biological metabolites in a liposomal system | Q77094970 | ||
| Antioxidant efficacy of phytoestrogens in chemical and biological model systems | Q77593106 | ||
| Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones | Q77664958 | ||
| Isoflavonoids do not inhibit in vivo lipid peroxidation in subjects with high-normal blood pressure | Q78067785 | ||
| Effect of isolated isoflavone supplementation on ABCA1-dependent cholesterol efflux potential in postmenopausal women | Q79563244 | ||
| Soy isoflavones lower serum total and LDL cholesterol in humans: a meta-analysis of 11 randomized controlled trials | Q80108602 | ||
| Urinary isoflavonoid excretion and soy consumption in three generations of Japanese women in Hawaii | Q80159984 | ||
| Effect of soy nuts on blood pressure and lipid levels in hypertensive, prehypertensive, and normotensive postmenopausal women | Q80392860 | ||
| Plasma phytoestrogens are not altered by probiotic consumption in postmenopausal women with and without a history of breast cancer | Q80397108 | ||
| Influence of 10 wk of soy consumption on plasma concentrations and excretion of isoflavonoids and on gut microflora metabolism in healthy adults | Q80475098 | ||
| Demographic, anthropometric, and lifestyle factors and dietary intakes in relation to daidzein-metabolizing phenotypes among premenopausal women in the United States | Q80836599 | ||
| Probiotic consumption does not enhance the cholesterol-lowering effect of soy in postmenopausal women | Q81073279 | ||
| Randomized controlled trial of the effects of soy protein containing isoflavones on vascular function in postmenopausal women | Q81247059 | ||
| Pasta naturally enriched with isoflavone aglycons from soy germ reduces serum lipids and improves markers of cardiovascular risk | Q81332096 | ||
| Isoflavone intake in persons at high risk of cardiovascular events: implications for vascular endothelial function and the carotid atherosclerotic burden | Q81406961 | ||
| Consumption of soy isoflavones does not affect plasma total homocysteine or asymmetric dimethylarginine concentrations in healthy postmenopausal women | Q81645272 | ||
| Long-term dietary habits affect soy isoflavone metabolism and accumulation in prostatic fluid in caucasian men | Q81806094 | ||
| Insights gained from 20 years of soy research | Q82081426 | ||
| Effect of soy protein varying in isoflavone content on serum lipids in healthy young men | Q82519150 | ||
| Different effects of isoflavones on vascular function in premenopausal and postmenopausal smokers and nonsmokers: NYMPH study | Q83163578 | ||
| An isoflavone metabolite reduces arterial stiffness and blood pressure in overweight men and postmenopausal women | Q83859591 | ||
| A cross-sectional study of equol producer status and self-reported vasomotor symptoms | Q85929413 | ||
| Relation between premenstrual syndrome and equol-production status | Q87774055 | ||
| Cognitive Effects of Soy Isoflavones in Patients with Alzheimer's Disease | Q34495510 | ||
| Soy, soy phytoestrogens and cardiovascular disease | Q34553051 | ||
| Association of dietary intake of soy, beans, and isoflavones with risk of cerebral and myocardial infarctions in Japanese populations: the Japan Public Health Center-based (JPHC) study cohort I. | Q34585135 | ||
| ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundat | Q34604622 | ||
| Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis | Q34604937 | ||
| Soy, red clover, and isoflavones and breast cancer: a systematic review | Q34658148 | ||
| F2-isoprostanes as an indicator and risk factor for coronary heart disease | Q34684200 | ||
| Soya isoflavone supplementation enhances spatial working memory in men. | Q34983836 | ||
| Soy and soy isoflavones in prostate cancer: a systematic review and meta-analysis of randomized controlled trials | Q34992997 | ||
| The pharmacokinetics of S-(-)equol administered as SE5-OH tablets to healthy postmenopausal women | Q35004789 | ||
| Cardiovascular risks in relation to daidzein metabolizing phenotypes among Chinese postmenopausal women | Q35095270 | ||
| Isoflavone soy protein supplementation and atherosclerosis progression in healthy postmenopausal women: a randomized controlled trial | Q35449373 | ||
| Soy provides modest benefits on endothelial function without affecting inflammatory biomarkers in adults at cardiometabolic risk | Q35671503 | ||
| Soy proteins and isoflavones reduce interleukin-6 but not serum lipids in older women: a randomized controlled trial | Q35675357 | ||
| Progressive coronary calcification despite intensive lipid-lowering treatment: a randomised controlled trial | Q35772460 | ||
| Coronary artery calcium, brain function and structure: the AGES-Reykjavik Study | Q35819364 | ||
| Equol production changes over time in pre-menopausal women | Q35870029 | ||
| Acute benefits of the microbial-derived isoflavone metabolite equol on arterial stiffness in men prospectively recruited according to equol producer phenotype: a double-blind randomized controlled trial. | Q35914108 | ||
| Effect of soy isoflavone supplementation on nitric oxide metabolism and blood pressure in menopausal women | Q35950597 | ||
| Prospective Study of Arterial Stiffness and Subsequent Cognitive Decline Among Community-Dwelling Older Japanese | Q35996305 | ||
| Long-term soy isoflavone supplementation and cognition in women: a randomized, controlled trial | Q36014731 | ||
| Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy | Q36136280 | ||
| Epidemiological profiles between equol producers and nonproducers: a genomewide association study of the equol-producing phenotype | Q36250137 | ||
| Effects of soy on health outcomes | Q36272142 | ||
| Urinary isoflavonoids and risk of coronary heart disease | Q36301954 | ||
| Vascular risk factors and Alzheimer's disease: are these risk factors for plaques and tangles or for concomitant vascular pathology that increases the likelihood of dementia? An evidence-based review | Q36317679 | ||
| Brachial-Ankle Pulse Wave Velocity and the Risk Prediction of Cardiovascular Disease: An Individual Participant Data Meta-Analysis. | Q36355691 | ||
| Food factors for atherosclerosis prevention: Asian perspective derived from analyses of worldwide dietary biomarkers. | Q36508466 | ||
| Soy foods and urinary isoprostanes: results from a randomized study in premenopausal women | Q36573832 | ||
| Estimated Asian adult soy protein and isoflavone intakes | Q36590662 | ||
| Association of arterial stiffness with progression of subclinical brain and cognitive disease | Q36603826 | ||
| Pulse wave velocity and cognitive decline in elders: the Health, Aging, and Body Composition study | Q36610883 | ||
| The Value of Delaying Alzheimer's Disease Onset | Q36852189 | ||
| Metabolism of dietary soy isoflavones to equol by human intestinal microflora--implications for health | Q36853704 | ||
| Soy protein reduces serum LDL cholesterol and the LDL cholesterol:HDL cholesterol and apolipoprotein B:apolipoprotein A-I ratios in adults with type 2 diabetes | Q44296304 | ||
| Isoflavones reduce arterial stiffness: a placebo-controlled study in men and postmenopausal women | Q44417106 | ||
| The phytoestrogen equol increases nitric oxide availability by inhibiting superoxide production: an antioxidant mechanism for cell-mediated LDL modification | Q44426600 | ||
| Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study | Q44438334 | ||
| Plasma isoflavone levels versus self-reported soy isoflavone levels in Asian-American women in Los Angeles County | Q44615162 | ||
| Limited lipid-lowering effects of regular consumption of whole soybean foods. | Q44696016 | ||
| Equol is a novel anti-androgen that inhibits prostate growth and hormone feedback | Q44697356 | ||
| Serum phytoestrogens and prostate cancer risk in a nested case-control study among Japanese men. | Q44726609 | ||
| Higher consumption of green tea may enhance equol production | Q44731833 | ||
| Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta | Q44798276 | ||
| Soy-isoflavone-enriched foods and markers of lipid and glucose metabolism in postmenopausal women: interactions with genotype and equol production | Q44819265 | ||
| Serum steroid hormones, sex hormone-binding globulin concentrations, and urinary hydroxylated estrogen metabolites in post-menopausal women in relation to daidzein-metabolizing phenotypes. | Q44897552 | ||
| Phytoestrogen concentrations in serum and spot urine as biomarkers for dietary phytoestrogen intake and their relation to breast cancer risk in European prospective investigation of cancer and nutrition-norfolk. | Q44907750 | ||
| The effect of soy protein isolate on bone metabolism | Q44913646 | ||
| Consumption of Lactobacillus acidophilus and Bifidobacterium longum do not alter urinary equol excretion and plasma reproductive hormones in premenopausal women | Q44949327 | ||
| Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women: a randomized controlled trial | Q44967448 | ||
| Effects of isolated isoflavonoids on lipids, lipoproteins, insulin sensitivity, and ghrelin in postmenopausal women | Q44968850 | ||
| Segment-specific effects of cardiovascular risk factors on carotid artery intima-medial thickness in women at midlife. | Q45009065 | ||
| Vascular function and atherosclerosis progression after 1 y of flavonoid intake in statin-treated postmenopausal women with type 2 diabetes: a double-blind randomized controlled trial | Q45046471 | ||
| Plasma antioxidant capacity in response to diets high in soy or animal protein with or without isoflavones | Q45217041 | ||
| Prospective study on usual dietary phytoestrogen intake and cardiovascular disease risk in Western women | Q45248526 | ||
| Daidzein supplementation decreases serum triglyceride and uric acid concentrations in hypercholesterolemic adults with the effect on triglycerides being greater in those with the GA compared with the GG genotype of ESR-β RsaI. | Q46039996 | ||
| Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: the ARIC MRI Study | Q46052847 | ||
| Soy protein with isoflavones has favorable effects on endothelial function that are independent of lipid and antioxidant effects in healthy postmenopausal women | Q46160872 | ||
| A cross sectional study to examine the association between dietary patterns and cognitive impairment in older Chinese people in Hong Kong | Q46169043 | ||
| Plasma isoflavones and subsequent risk of prostate cancer in a nested case-control study: the Japan Public Health Center | Q46239304 | ||
| Impact of soy supplementation on sex steroids and vascular inflammation markers in postmenopausal women using tibolone: role of equol production capability | Q46378668 | ||
| Effects of including soy protein in a blood cholesterol-lowering diet on markers of cardiac risk in men and in postmenopausal women with and without hormone replacement therapy | Q46460217 | ||
| Urinary phytoestrogen concentrations in the U.S. population (1999-2000). | Q46521217 | ||
| Aggressive versus moderate lipid-lowering therapy in hypercholesterolemic postmenopausal women: Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES). | Q46595096 | ||
| Daidzein-metabolizing phenotypes in relation to serum hormones and sex hormone binding globulin, and urinary estrogen metabolites in premenopausal women in the United States. | Q46597338 | ||
| Dietary and lifestyle correlates of urinary excretion status of equol in Japanese women | Q46621122 | ||
| Effect of soy protein containing isoflavones on blood lipids in moderately hypercholesterolemic adults: a randomized controlled trial | Q46644404 | ||
| Carotid- intima media thickness is independently associated with cognitive decline. The INVADE study | Q46834039 | ||
| Soy-isoflavone-enriched foods and inflammatory biomarkers of cardiovascular disease risk in postmenopausal women: interactions with genotype and equol production | Q46839401 | ||
| Greater habitual soyfood consumption is associated with decreased carotid intima-media thickness and better plasma lipids in Chinese middle-aged adults | Q46893782 | ||
| Equol production capability is associated with favorable vascular function in postmenopausal women using tibolone; no effect with soy supplementation | Q46931117 | ||
| Genistein protects hippocampal neurons against injury by regulating calcium/calmodulin dependent protein kinase IV protein levels in Alzheimer's disease model rats | Q47136937 | ||
| Carotid intima-media thickness measurements in intervention studies: design options, progression rates, and sample size considerations: a point of view | Q47437281 | ||
| Soy isoflavone genistein attenuates lipopolysaccharide-induced cognitive impairments in the rat via exerting anti-oxidative and anti-inflammatory effects | Q47442092 | ||
| Soy food and isoflavone intake reduces the risk of cognitive impairment in elderly Japanese women | Q47554361 | ||
| Soy food consumption is associated with lower risk of coronary heart disease in Chinese women | Q47654096 | ||
| Vasorelaxant and antioxidant activity of the isoflavone metabolite equol in carotid and cerebral arteries | Q48287613 | ||
| Eating soya improves human memory | Q48620640 | ||
| Carotid atherosclerosis predicts lower cognitive test results: a 7-year follow-up study of 4,371 stroke-free subjects - the Tromsø study | Q48765537 | ||
| Clearing Amyloid-β through PPARγ/ApoE Activation by Genistein is a Treatment of Experimental Alzheimer's Disease | Q48895750 | ||
| Soy and the risk of type 2 diabetes mellitus: A systematic review and meta-analysis of observational studies | Q50178063 | ||
| A Mitochondrial Biomarker-Based Study of S-Equol in Alzheimer's Disease Subjects: Results of a Single-Arm, Pilot Trial. | Q50592925 | ||
| Effects of isoflavone-containing soya protein on ex vivo cholesterol efflux, vascular function and blood markers of CVD risk in adults with moderately elevated blood pressure: a dose-response randomised controlled trial. | Q50917150 | ||
| Whole soy, but not purified daidzein, had a favorable effect on improvement of cardiovascular risks: a 6-month randomized, double-blind, and placebo-controlled trial in equol-producing postmenopausal women. | Q51330900 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial | Q6936496 |
| P433 | issue | 2 | |
| P921 | main subject | brain | Q1073 |
| diet | Q474191 | ||
| P304 | page(s) | 114-135 | |
| P577 | publication date | 2019-01-01 | |
| P1433 | published in | Current cardiology reviews | Q26842280 |
| P1476 | title | Effect of S-equol and Soy Isoflavones on Heart and Brain | |
| P478 | volume | 15 |
| Q64093116 | Clinical Advances in Immunonutrition and Atherosclerosis: A Review |
| Q90029807 | Effects of soy isoflavones on cognitive function: a systematic review and meta-analysis of randomized controlled trials |
| Q90133060 | Equol: A Bacterial Metabolite from The Daidzein Isoflavone and Its Presumed Beneficial Health Effects |
| Q89511541 | Gut Microbiota and Its Metabolites in Atherosclerosis Development |
| Q99365602 | Soy intake and chronic disease risk: findings from prospective cohort studies in Japan |
Search more.